|
Index of reports
> Cases with Hypoaesthesia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Evista (Raloxifene) where reactions include hypoaesthesia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Evista side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-27
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Nausea, Breast Cancer Female, Hypoaesthesia, Hypertension
Drug(s) suspected as cause:
Tamoxifen Citrate
Dosage: unk
Indication: Breast Cancer Female
Depakote
Dosage: 700 mg, daily
Start date: 2011-01-01
Evista
Dosage: unk
Indication: Breast Cancer Female
Zoloft
Dosage: 100 mg,daily
Indication: Mental Disorder
Start date: 2001-01-01
Geodon
Dosage: 40 mg, 2x/day
Indication: Bipolar Disorder
Lithium Carbonate
Dosage: unk
End date: 2011-05-15
Geodon
Dosage: unk
Lamictal
Dosage: 75 mg, daily
Start date: 2011-01-01
Geodon
Dosage: 60 mg, unk
Indication: Bipolar I Disorder
Start date: 2001-01-01
Other drugs received by patient: Ambien
Possible Evista side effects in 59 year old female
Reported by a physician from United States on 2012-05-09
Patient: 59 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Joint Instability, Contusion, Tinnitus, Urinary Incontinence, Hand Fracture, Arthropathy, Deafness Unilateral, Mouth Breathing, Eyelid Ptosis, Carpal Tunnel Syndrome, Actinic Keratosis, Anxiety Disorder, Hypotension, Hyperglycaemia, Osteomyelitis Chronic, Hypoaesthesia, Osteonecrosis, Increased Tendency To Bruise, Vision Blurred, Vaginal Infection, Parosmia, Paresis, Tooth Abscess, Skin Exfoliation, Post Procedural Complication, Parkinson's Disease, Fracture Nonunion, Periarthritis, Oral Herpes, Periodontitis, Viith Nerve Paralysis, Foot Fracture, Gingival Oedema, Neuropathy Peripheral, Bone Loss, Intervertebral Disc Degeneration, Rotator Cuff Syndrome, Depression, Injury, Tympanosclerosis, Trismus, Tooth Fracture, Cataract, Spondylolisthesis, Dental Caries, Arrhythmia, Osteoarthritis, Dysgeusia, Panic Attack, Oral Pain, Osteonecrosis of JAW, Impaired Healing, Sinus Disorder, JAW Disorder, Pollakiuria, Dysaesthesia, Bronchitis, Tooth Disorder, Arthritis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2002-01-01
End date: 2005-12-01
Fosamax
Administration route: Oral
Start date: 2006-04-01
End date: 2006-06-01
Fosamax
Administration route: Oral
Start date: 2006-07-01
End date: 2007-12-01
Actonel
Administration route: Oral
Indication: Osteoporosis
Start date: 2009-08-01
End date: 2009-11-01
Evista
Administration route: Oral
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-01
End date: 2009-07-01
Other drugs received by patient: Arthrotec; Synthroid
Possible Evista side effects in 59 year old female
Reported by a physician from United States on 2012-04-26
Patient: 59 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Joint Instability, Foot Deformity, Tinnitus, Contusion, Urinary Incontinence, Hand Fracture, Arthropathy, Deafness Unilateral, Mouth Breathing, Irritable Bowel Syndrome, Eyelid Ptosis, Carpal Tunnel Syndrome, Actinic Keratosis, Anxiety Disorder, Hyperglycaemia, Hypotension, Osteomyelitis Chronic, Hypoaesthesia, Osteonecrosis, Increased Tendency To Bruise, Vision Blurred, Parosmia, Paresis, Skin Exfoliation, Tooth Abscess, Post Procedural Complication, Parkinson's Disease, Periodontitis, Periarthritis, Fracture Nonunion, Oral Herpes, Viith Nerve Paralysis, Foot Fracture, Gingival Oedema, Neuropathy Peripheral, Bone Loss, Intervertebral Disc Degeneration, Rotator Cuff Syndrome, Injury, Depression, Tympanosclerosis, Cataract, Trismus, Tooth Fracture, Spondylolisthesis, Dental Caries, Arrhythmia, Osteoarthritis, Dysgeusia, Panic Attack, Osteonecrosis of JAW, Oral Pain, Impaired Healing, Sinus Disorder, JAW Disorder, Pollakiuria, Dysaesthesia, Bronchitis, Tooth Disorder, Arthritis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Evista
Administration route: Oral
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-01
End date: 2009-07-01
Fosamax
Administration route: Oral
Start date: 2006-07-01
End date: 2007-12-01
Fosamax
Administration route: Oral
Start date: 2006-04-01
End date: 2006-06-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2002-01-01
End date: 2005-12-01
Actonel
Administration route: Oral
Indication: Osteoporosis
Start date: 2009-08-01
End date: 2009-11-01
Other drugs received by patient: Arthrotec; Synthroid
Possible Evista side effects in 59 year old female
Reported by a physician from United States on 2012-03-01
Patient: 59 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Joint Instability, Tinnitus, Contusion, Hand Fracture, Arthropathy, Deafness Unilateral, Mouth Breathing, Eyelid Ptosis, Irritable Bowel Syndrome, Carpal Tunnel Syndrome, Actinic Keratosis, Anxiety Disorder, Hyperglycaemia, Hypotension, Osteomyelitis Chronic, Hypoaesthesia, Increased Tendency To Bruise, Vision Blurred, Parosmia, Paresis, Tooth Abscess, Skin Exfoliation, Post Procedural Complication, Parkinson's Disease, Fracture Nonunion, Periarthritis, Periodontitis, Oral Herpes, Viith Nerve Paralysis, Gingival Oedema, Foot Fracture, Bone Loss, Neuropathy Peripheral, Intervertebral Disc Degeneration, Rotator Cuff Syndrome, Injury, Tympanosclerosis, Tooth Fracture, Trismus, Cataract, Spondylolisthesis, Dental Caries, Osteoarthritis, Dysgeusia, Panic Attack, Oral Pain, Impaired Healing, Osteonecrosis of JAW, Sinus Disorder, JAW Disorder, Dysaesthesia, Bronchitis, Tooth Disorder, Arthritis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Evista
Administration route: Oral
Fosamax
Administration route: Oral
Start date: 2006-07-01
End date: 2007-12-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-01
End date: 2009-07-01
Fosamax
Administration route: Oral
Start date: 2006-04-01
End date: 2006-06-01
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2002-01-01
End date: 2005-12-01
Actonel
Administration route: Oral
Indication: Osteoporosis
Start date: 2009-08-01
End date: 2009-11-01
Other drugs received by patient: Arthrotec; Synthroid
Possible Evista side effects in 59 year old female
Reported by a physician from United States on 2012-02-23
Patient: 59 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Contusion, Tooth Abscess, Post Procedural Complication, Parkinson's Disease, Hand Fracture, Osteomyelitis, Periodontitis, Oral Herpes, Fracture Nonunion, Viith Nerve Paralysis, Foot Fracture, Bone Loss, Neuropathy Peripheral, Intervertebral Disc Degeneration, Rotator Cuff Syndrome, Carpal Tunnel Syndrome, Injury, Cough, Tooth Fracture, Anxiety Disorder, Spondylolisthesis, Dental Caries, Hypotension, Hypoaesthesia, Osteoarthritis, Panic Attack, Impaired Healing, Osteonecrosis of JAW, Sinus Disorder, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2002-01-01
End date: 2005-12-01
Fosamax
Administration route: Oral
Start date: 2006-07-01
End date: 2007-12-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-01
End date: 2009-07-01
Fosamax
Administration route: Oral
Start date: 2006-04-01
End date: 2006-06-01
Actonel
Administration route: Oral
Indication: Osteoporosis
Start date: 2009-08-01
End date: 2009-11-01
Evista
Administration route: Oral
Other drugs received by patient: Arthrotec; Synthroid
Possible Evista side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-27
Patient: female
Reactions: Injection Site Haematoma, Drug Ineffective, Injection Site Pain, Blood Calcium Increased, Hypoaesthesia, Tremor, Injection Site Pruritus, Dysstasia, Injection Site Erythema, Insomnia, Injection Site Streaking, Dizziness, Memory Impairment, Gait Disturbance, Hydrocephalus, Asthenia
Drug(s) suspected as cause:
Evista
Dosage: 60 mg, daily (1/d)
Indication: Osteoporosis
Forteo
Dosage: 20 ug, qd
Forteo
Dosage: 20 ug, daily (1/d)
Forteo
Dosage: 20 ug, daily (1/d)
Forteo
Dosage: 20 ug, daily (1/d)
Forteo
Dosage: 20 ug, daily (1/d)
Forteo
Dosage: 20 ug, daily (1/d)
Indication: Osteoporosis
Forteo
Dosage: 20 ug, daily (1/d)
Other drugs received by patient: Metoprolol Tartrate; Spironolactone W / Hydrochlorothiazide; Mirtazapine; Namenda
Possible Evista side effects in 59 year old female
Reported by a physician from United States on 2012-01-25
Patient: 59 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Contusion, Tooth Abscess, Post Procedural Complication, Osteomyelitis, Parkinson's Disease, Hand Fracture, Oral Herpes, Periodontitis, Fracture Nonunion, Viith Nerve Paralysis, Foot Fracture, Bone Loss, Neuropathy Peripheral, Intervertebral Disc Degeneration, Rotator Cuff Syndrome, Injury, Carpal Tunnel Syndrome, Cough, Tooth Fracture, Anxiety Disorder, Spondylolisthesis, Hypotension, Dental Caries, Hypoaesthesia, Osteoarthritis, Panic Attack, Osteonecrosis of JAW, Impaired Healing, Sinus Disorder, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteoporosis
Start date: 2002-01-01
End date: 2005-12-01
Alendronate Sodium
Administration route: Oral
Indication: Osteoporosis
Start date: 2008-03-01
End date: 2009-07-01
Fosamax
Administration route: Oral
Start date: 2006-04-01
End date: 2006-06-01
Fosamax
Administration route: Oral
Start date: 2006-07-01
End date: 2007-12-01
Actonel
Administration route: Oral
Indication: Osteoporosis
Start date: 2009-08-01
End date: 2009-11-01
Evista
Administration route: Oral
Other drugs received by patient: Arthrotec; Synthroid
Possible Evista side effects in female
Reported by a consumer/non-health professional from United States on 2011-12-01
Patient: female
Reactions: Hypersensitivity, Benign Ovarian Tumour, Injection Site Haemorrhage, Endometriosis, Fear, Chills, Pain, Intentional Drug Misuse, Pallor, Hyperhidrosis, Bone Loss, Palpitations, Uterine Leiomyoma, Dizziness, Sinusitis, Polydipsia, Swelling Face, Chest Discomfort, Dyspnoea, Rhinitis, Rash, Hypoaesthesia, Nasal Congestion, Discomfort, Exercise Tolerance Decreased, Blood Glucose Decreased, Pigmentation Disorder, JAW Disorder, Tooth Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Forteo
Dosage: 20 ug, qd
Indication: Osteoporosis
Start date: 2011-04-01
Forteo
Dosage: 20 ug, qd
Start date: 2011-06-24
End date: 2011-07-05
Evista
Dosage: 60 mg, qd
Indication: Osteopenia
Forteo
Dosage: 20 ug, qd
End date: 2011-06-11
|
